Under the assumption of Mendelian randomization, 0.1 pg/mL reduction of circulating IL-6 was associated with a 6% (95% CI: 1.04–1.12) and 22% (95% CI: 1.14–1.50) increased risk of RA in overall and Asian populations, respectively. Here, IL6 is linked to rheumatoid arthritis.